Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan M Granoff

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Vaccine|May 30, 2009
Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal diseaseDan M Granoff
Human Vaccines & Immunotherapeutics|June 29, 2013
Portrait: coincidences, convergences and opportunitiesDan M Granoff
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2010
Review of meningococcal group B vaccinesDan M Granoff
The Pediatric Infectious Disease Journal|December 25, 2012
Commentary: European Medicines Agency recommends approval of a broadly protective vaccine against serogroup B meningococcal diseaseDan M Granoff
The New England Journal of Medicine|November 1, 2016
Meningococcal B Vaccine during a University OutbreakDan M Granoff
Blood|June 21, 2017
Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adultsMonica Konar, Dan M Granoff
The Pediatric Infectious Disease Journal|September 13, 2007
Reconsideration of the use of meningococcal polysaccharide vaccineDan M Granoff, Andrew J Pollard
Microbiology (Reading, England)|July 4, 2009
The modular architecture of meningococcal factor H-binding proteinPeter T Beernink, Dan M Granoff
The Pediatric Infectious Disease Journal|June 15, 2004
Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccineDan M Granoff, Shannon L Harris
Infection and Immunity|March 26, 2008
Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccinesPeter T Beernink, Dan M Granoff
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Vaccine|May 30, 2009
Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal diseaseDan M Granoff
Human Vaccines & Immunotherapeutics|June 29, 2013
Portrait: coincidences, convergences and opportunitiesDan M Granoff
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2010
Review of meningococcal group B vaccinesDan M Granoff
The Pediatric Infectious Disease Journal|December 25, 2012
Commentary: European Medicines Agency recommends approval of a broadly protective vaccine against serogroup B meningococcal diseaseDan M Granoff
The New England Journal of Medicine|November 1, 2016
Meningococcal B Vaccine during a University OutbreakDan M Granoff
Blood|June 21, 2017
Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adultsMonica Konar, Dan M Granoff
The Pediatric Infectious Disease Journal|September 13, 2007
Reconsideration of the use of meningococcal polysaccharide vaccineDan M Granoff, Andrew J Pollard
Microbiology (Reading, England)|July 4, 2009
The modular architecture of meningococcal factor H-binding proteinPeter T Beernink, Dan M Granoff
The Pediatric Infectious Disease Journal|June 15, 2004
Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccineDan M Granoff, Shannon L Harris
Infection and Immunity|March 26, 2008
Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccinesPeter T Beernink, Dan M Granoff
Pageof 10